SCHIMMEL PAUL
SEC insider (Form 3/4/5 filer). CIK 0001236447. Director at aTYR PHARMA INC (ATYR). 5 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in SAN DIEGO, CA.
Companies SCHIMMEL PAUL has filed insider reports for
- aTYR PHARMA INC (ATYR): Director
SCHIMMEL PAUL
CIK: 0001236447
Transaction Breakdown
Open Market Buys (P)3 (60.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATYR
aTYR PHARMA INC
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 27, 2026ATYR
aTYR PHARMA INC
PurchaseIndirect100K shares at avg. $0.50$50K - May 11, 2026ATYR
aTYR PHARMA INC
AwardDirectStock Option (right to buy)
50K shares- - Oct 9, 2025ATYR
aTYR PHARMA INC
PurchaseIndirect318K shares at avg. $0.94$299K - Oct 8, 2025ATYR
aTYR PHARMA INC
PurchaseIndirect682K shares at avg. $0.90$612K - May 1, 2025ATYR
aTYR PHARMA INC
AwardDirectStock Option (right to buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 27, 2026 | ATYR aTYR PHARMA INC | Purchase | 100,000 | $0.50 | $49,630 | Indirect |
| May 11, 2026 | ATYR aTYR PHARMA INC | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Oct 9, 2025 | ATYR aTYR PHARMA INC | Purchase | 317,999 | $0.94 | $299,364 | Indirect |
| Oct 8, 2025 | ATYR aTYR PHARMA INC | Purchase | 682,001 | $0.90 | $612,437 | Indirect |
| May 1, 2025 | ATYR aTYR PHARMA INC | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
1-5 of 5 transactions